CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study
Contributeurs/tricesChammartin, Frédérique; Darling, Katharine; Abela, Irene A![orcid](assets/images/orcid.png)
; Battegay, Manuel; Furrer, Hansjakob; Calmy, Alexandra![orcid](assets/images/orcid.png)
; Bernasconi, Enos; Schmid, Patrick; Hoffmann, Matthias; Bucher, Heiner C; and the Swiss HIV Cohort Study
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
Collaborateurs/tricesKaiser, Laurent; Keiser, Olivia![orcid](assets/images/orcid.png)
; Martinez De Tejada Weber, Begona; Yerly Ferrillo, Sabine
![orcid](assets/images/orcid.png)
Publié dansJournal of acquired immune deficiency syndromes, vol. 91, no. 5, p. 508-515
Date de publication2022-12-15
Date de mise en ligne2022-09-23
Résumé
Mots-clés
- Humans
- CD4-CD8 Ratio
- HIV Infections / complications
- HIV Infections / drug therapy
- Cohort Studies
- Prognosis
- Cardiovascular Diseases / drug therapy
- Switzerland
- CD4-Positive T-Lymphocytes
- CD8-Positive T-Lymphocytes
- Anti-Retroviral Agents / adverse effects
- Viral Load
- Biomarkers
- Coronary Disease / epidemiology
- Stroke / epidemiology
- CD4 Lymphocyte Count
- Anti-HIV Agents / adverse effects
Structure d'affiliation
Groupe de recherche
Citation (format ISO)
CHAMMARTIN, Frédérique et al. CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study. In: Journal of acquired immune deficiency syndromes, 2022, vol. 91, n° 5, p. 508–515. doi: 10.1097/QAI.0000000000003094
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:173272
- DOI : 10.1097/QAI.0000000000003094
- PMID : 36150371
- PMCID : PMC7613804
ISSN du journal1525-4135